News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER launches second phase of adult observational study
Throughout this phase, RECOVER will continue to collect information from about 5,000 people for 2 years to build a deeper understanding of how Long COVID affects people over time.
Feature
169 Results
169 Results
NIH RECOVER makes Long COVID research data easier to access
De-identified data from thousands of adults with Long COVID are now available to researchers.
News Release
R3 Seminar Recap: PASC in Children: State of the Science and Future Directions
During the April 23rd, RECOVER Research Review (R3) Seminar, the speakers discussed our current knowledge of Long COVID in children, including epidemiology and risk factors, symptoms, underlying mechanisms that cause symptoms, and functional outcomes.
R3 Seminar Recap
R3 Seminar Recap: Patterns and Prevention of Long COVID: Findings from RECOVER EHR Cohort Studies
During the March 19th RECOVER Research Review (R3) Seminar, research presented findings about vaccine effectiveness against Long COVID in children and the association between SARS-CoV-2 infection and symptoms and conditions in children and adults.
R3 Seminar Recap
NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction
RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
News Release
R3 Seminar Recap: Understanding Neurological Manifestations of PASC and Cerebral Vascular Injury
During the February 13th RECOVER Research Review (R3) Seminar, several pathobiology study awardees presented about the mechanisms of neurological (brain and nervous system) symptoms of Long COVID.
R3 Seminar Recap
Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
Q&A
NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.
News Release
R3 Seminar Recap: RECOVER Observational Studies Consortium: Where we are and where we are headed
During the January 23rd RECOVER Research Review (R3) Seminar, researchers presented on the progress and future directions of the RECOVER Initiative. Speakers from the RECOVER adult, pediatric, and autopsy cohorts provided an overview of the progress to date, what is in the pipeline and the ultimate promise of RECOVER for each of the cohorts. A review of the current state of the science of Long COVID and gaps in knowledge was also discussed.
R3 Seminar Recap